Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 28, 2018

Total Value: $171M (100.0% shares, 0.0% debt)

Holdings (31)

— AMARIN CORP PLC -ADR 14.3%

Value $24.41M Shares 1,500,000 Est. Cost $3.01 Unrealized —

— APOLLO ENDOSURGERY INC 10.8%

Value $18.48M Shares 2,577,996 Est. Cost $4.75 Unrealized —

— BIOSPECIFICS TECHNOLOGIES 9.8%

Value $16.68M Shares 285,259 Est. Cost $45.13 Unrealized —

— BIODELIVERY SCIENCES INTL 7.1%

Value $12.07M Shares 4,311,103 Est. Cost $2.54 Unrealized —

— CTI BIOPHARMA CORP 6.7%

Value $11.45M Shares 5,302,063 Est. Cost $3.25 Unrealized —

— VIVEVE MEDICAL INC 6.0%

Value $10.32M Shares 3,849,711 Est. Cost $6.92 Unrealized —

— MELINTA THERAPEUTICS INC 4.5%

Value $7.736M Shares 1,958,595 Est. Cost $4.01 Unrealized —

VNDA VANDA PHARMACEUTICALS INC 4.4%

Value $7.45M Shares 324,600 Est. Cost $14.90 Unrealized +37.0%

CPIX CUMBERLAND PHARMACEUTICALS 4.1%

Value $6.957M Shares 1,218,401 Est. Cost $5.83 Unrealized +1.1%

— ALIMERA SCIENCES INC 4.0%

Value $6.848M Shares 6,987,856 Est. Cost $1.18 Unrealized —

— OPHTHOTECH CORP 3.2%

Value $5.486M Shares 2,324,782 Est. Cost $3.80 Unrealized —

— NOVELION THERAPEUTICS INC 3.0%

Value $5.118M Shares 1,728,887 Est. Cost $8.14 Unrealized —

— OXFORD IMMUNOTEC GLOBAL PLC 2.1%

Value $3.666M Shares 225,877 Est. Cost $16.23 Unrealized —

— CORREVIO PHARMA CORP 2.1%

Value $3.611M Shares 898,157 Est. Cost $3.78 Unrealized —

— OPIANT PHARMACEUTICALS INC 1.9%

Value $3.32M Shares 185,887 Est. Cost $17.86 Unrealized —

— FOAMIX PHARMACEUTICALS LTD 1.8%

Value $3.158M Shares 551,078 Est. Cost $5.73 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 1.8%

Value $3.053M Shares 138,100 Est. Cost $13.52 Unrealized 0.0%

— CIDARA THERAPEUTICS INC 1.7%

Value $2.887M Shares 656,148 Est. Cost $4.92 Unrealized —

— HTG MOLECULAR DIAGNOSTICS 1.6%

Value $2.705M Shares 535,590 Est. Cost $3.26 Unrealized —

ATEC ALPHATEC HOLDINGS INC 1.5%

Value $2.533M Shares 751,756 Est. Cost $3.55 Unrealized -11.2%

SPRO SPERO THERAPEUTICS INC 1.4%

Value $2.38M Shares 226,444 Est. Cost $11.61 Unrealized 0.0%

— MOLECULAR TEMPLATES INC 1.2%

Value $2.039M Shares 378,295 Est. Cost $5.39 Unrealized —

ALDX ALDEYRA THERAPEUTICS INC 1.2%

Value $2.001M Shares 145,000 Est. Cost $8.11 Unrealized 0.0%

— CATABASIS PHARMACEUTICALS IN 1.0%

Value $1.733M Shares 2,166,154 Est. Cost $0.96 Unrealized —

XENE XENON PHARMACEUTICALS INC 0.8%

Value $1.32M Shares 100,000 Est. Cost $11.59 Unrealized 0.0%

— NEOS THERAPEUTICS INC 0.6%

Value $1.105M Shares 227,919 Est. Cost $4.85 Unrealized —

— SPRING BANK PHARMACEUTICALS 0.5%

Value $856K Shares 71,050 Est. Cost $12.05 Unrealized —

— CANCER GENETICS INC 0.4%

Value $639K Shares 614,411 Est. Cost $1.85 Unrealized —

— SCYNEXIS INC 0.3%

Value $539K Shares 448,777 Est. Cost $1.20 Unrealized —

SRTS SENSUS HEALTHCARE INC 0.2%

Value $317K Shares 37,858 Est. Cost $7.24 Unrealized 0.0%

— DOVA PHARMACEUTICALS INC 0.1%

Value $145K Shares 6,900 Est. Cost $21.01 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	AMARIN CORP PLC -ADR	1,500,000	$24.41M	14.3%	$3.01	—	SPONS ADR NEW	023111206
—	APOLLO ENDOSURGERY INC	2,577,996	$18.48M	10.8%	$4.75	—	COM	03767D108
—	BIOSPECIFICS TECHNOLOGIES	285,259	$16.68M	9.8%	$45.13	—	COM	090931106
—	BIODELIVERY SCIENCES INTL	4,311,103	$12.07M	7.1%	$2.54	—	COM	09060J106
—	CTI BIOPHARMA CORP	5,302,063	$11.45M	6.7%	$3.25	—	COM NEW	12648L601
—	VIVEVE MEDICAL INC	3,849,711	$10.32M	6.0%	$6.92	—	COM NEW	92852W204
—	MELINTA THERAPEUTICS INC	1,958,595	$7.736M	4.5%	$4.01	—	COM	58549G100
VNDA	VANDA PHARMACEUTICALS INC	324,600	$7.45M	4.4%	$14.90	+37.0%	COM	921659108
CPIX	CUMBERLAND PHARMACEUTICALS	1,218,401	$6.957M	4.1%	$5.83	+1.1%	COM	230770109
—	ALIMERA SCIENCES INC	6,987,856	$6.848M	4.0%	$1.18	—	COM	016259103
—	OPHTHOTECH CORP	2,324,782	$5.486M	3.2%	$3.80	—	COM	683745103
—	NOVELION THERAPEUTICS INC	1,728,887	$5.118M	3.0%	$8.14	—	COM NEW	67001K202
—	OXFORD IMMUNOTEC GLOBAL PLC	225,877	$3.666M	2.1%	$16.23	—	ORD SHS	G6855A103
—	CORREVIO PHARMA CORP	898,157	$3.611M	2.1%	$3.78	—	COM	22026V105
—	OPIANT PHARMACEUTICALS INC	185,887	$3.32M	1.9%	$17.86	—	COM	683750103
—	FOAMIX PHARMACEUTICALS LTD	551,078	$3.158M	1.8%	$5.73	—	SHS	M46135105
KALV	KALVISTA PHARMACEUTICALS INC	138,100	$3.053M	1.8%	$13.52	0.0%	COM	483497103
—	CIDARA THERAPEUTICS INC	656,148	$2.887M	1.7%	$4.92	—	COM	171757107
—	HTG MOLECULAR DIAGNOSTICS	535,590	$2.705M	1.6%	$3.26	—	COM	40434H104
ATEC	ALPHATEC HOLDINGS INC	751,756	$2.533M	1.5%	$3.55	-11.2%	COM NEW	02081G201
SPRO	SPERO THERAPEUTICS INC	226,444	$2.38M	1.4%	$11.61	0.0%	COM	84833T103
—	MOLECULAR TEMPLATES INC	378,295	$2.039M	1.2%	$5.39	—	COM	608550109
ALDX	ALDEYRA THERAPEUTICS INC	145,000	$2.001M	1.2%	$8.11	0.0%	COM	01438T106
—	CATABASIS PHARMACEUTICALS IN	2,166,154	$1.733M	1.0%	$0.96	—	COM	14875P107
XENE	XENON PHARMACEUTICALS INC	100,000	$1.32M	0.8%	$11.59	0.0%	COM	98420N105
—	NEOS THERAPEUTICS INC	227,919	$1.105M	0.6%	$4.85	—	COM	64052L106
—	SPRING BANK PHARMACEUTICALS	71,050	$856K	0.5%	$12.05	—	COM	849431101
—	CANCER GENETICS INC	614,411	$639K	0.4%	$1.85	—	COM	13739U104
—	SCYNEXIS INC	448,777	$539K	0.3%	$1.20	—	COM	811292101
SRTS	SENSUS HEALTHCARE INC	37,858	$317K	0.2%	$7.24	0.0%	COM	81728J109
—	DOVA PHARMACEUTICALS INC	6,900	$145K	0.1%	$21.01	—	COM	25985T102